Topical Analgesia Post-Haemorrhoidectomy
A Prospective, Multicentre, Double-Blinded Randomised Controlled Trial Comparing Topical Metronidazole, Diltiazem and Lidocaine on Post-Operative Pain Following Excisional Haemorrhoidectomy
Sponsor: University of Auckland, New Zealand
Listed as NCT04276298, this PHASE2/PHASE3 trial focuses on Hemorrhoid Pain and Hemorrhoids and remains completed. Sponsored by University of Auckland, New Zealand, it has been updated 8 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jun 2022 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
Status: Recruiting → Completed
-
Jan 2021 — Jun 2022 [monthly]
Recruiting PHASE2_PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
▶ Show 3 earlier versions
-
Oct 2020 — Dec 2020 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
Apr 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Mar 2020 — Apr 2020 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Auckland, New Zealand
For direct contact, visit the study record on ClinicalTrials.gov .